Zhou et al. (25) reported that inhibition of MEF2A with siRNA can accelerate atherosclerosis in apoE−/− mice, and its molecular mechanism is involved in the increase of pro-inflammatory cytokines such as MCP-1, MMP-8, IL-6 and TNF-α. The gene discussed is MEF2A; the disease is atherosclerosis.